Specialization
I specialize in severe and complex mental conditions that are difficult to treat with standard treatment. Patients who have multiple diagnoses or serious underlying physical illnesses often come to me. My main task is to find the key to treatment where conventional methods do not work. I use modern approaches that can be effective even in the most difficult cases: electroconvulsive therapy, transcranial magnetic stimulation, plasmapheresis, and special combination treatment regimens.
Competencies
The peculiarity and experience of A.B. Kostyukova's clinical work as a psychiatrist is determined by the variety and nature of the psychiatric pathology of the patients she oversees (resistance, intolerance, comorbidity, acute, combined and complicated conditions, including somatic pathology). The use of methods to overcome therapeutic resistance in schizophrenia and other psychotic disorders, in particular the use of electro-convulsive therapy, transcranial magnetic stimulation, plasmapheresis and augmentation of pharmacological agents.
Experience and education
2007 2009 Moscow Research Institute of Psychiatry of the Ministry of Health of the Russian Federation, Faculty of Psychiatry
Professional development
2023 Advanced training under the program "Organization of trafficking in narcotic drugs and psychotropic substances and quality management of healthcare". Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation (Moscow)2022 Advanced training under the program "Healthcare Organization and Public Health". Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation (Moscow)
2018 2019 Professional retraining "MBA-Intensive. A course for managers." CHUDPO TSK PvK Expert (Moscow)
Publications
Other articles
Participation in research
2010 2012 Clinical Psychopharmacology Phase II H8Y-MC-HBBM "Eli Lilly Vostok S.A.", Co-researcher
2010 2012 Clinical Psychopharmacology Phase II H8Y-MC-HBVO "Eli Lilly Vostok S.A.", co-researcher
2012 2015 Clinical Psychopharmacology Phase IIIb RGH-188-005 "Gideon Richter PLC", Co-researcher
Publications
2013 Neuroinflammatory hypothesis of schizophrenia and some new therapeutic approaches
Reviews
Leave a reviewQuestions and answers
Ask a questionand new products of the EMC